Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Ferrer

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Eclinicalmedicine|June 30, 2022
Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective studyVeronica Davalos, Carlos A García-Prieto, Gerardo Ferrer, et al.
Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
Cell Reports. Medicine|September 25, 2025
The multiomics blueprint of the individual with the most extreme lifespanEloy Santos-Pujol, Aleix Noguera-Castells, Marta Casado-Pelaez, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia & Lymphoma|April 5, 2017
FcγRIIb expression in early stage chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Eva Puy Vicente, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Eclinicalmedicine|June 30, 2022
Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective studyVeronica Davalos, Carlos A García-Prieto, Gerardo Ferrer, et al.
Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.
Blood Advances|April 23, 2026
DNA methylation-based classification of hematolymphoid neoplasmsAnnapurna Saksena, Christin Siewert, Rust Turakulov, et al.
Cell Reports. Medicine|September 25, 2025
The multiomics blueprint of the individual with the most extreme lifespanEloy Santos-Pujol, Aleix Noguera-Castells, Marta Casado-Pelaez, et al.
Pageof 9